- Report
- August 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- October 2023
- 145 Pages
Global
From €2867EUR$3,150USD£2,435GBP
- Report
- November 2021
- 120 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 84 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- January 2024
- 114 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 146 Pages
Global
From €3211EUR$3,528USD£2,727GBP
€3777EUR$4,150USD£3,208GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
The Kidney Function Test market within the In Vitro Diagnostics sector is focused on the development and production of tests that measure the performance of the kidneys. These tests are used to detect and diagnose kidney diseases, as well as to monitor the progress of treatment. Tests may measure the levels of creatinine, urea, electrolytes, and other substances in the blood or urine. They may also measure the glomerular filtration rate, which is an indicator of kidney function.
The Kidney Function Test market is driven by the increasing prevalence of kidney diseases, as well as the need for early diagnosis and treatment. The market is also supported by advances in technology, such as automated testing systems, which have improved the accuracy and speed of testing.
Some companies in the Kidney Function Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Show Less Read more